Gene
Entrez ID Entrez Gene ID - the GENE ID in NCBI Gene database.
8648
Gene name Gene Name - the full gene name approved by the HGNC.
Nuclear receptor coactivator 1
Gene symbol Gene Symbol - the official gene symbol approved by the HGNC.
NCOA1
Synonyms (NCBI Gene) Gene synonyms aliases
F-SRC-1, KAT13A, RIP160, SRC1, bHLHe42, bHLHe74
Chromosome Chromosome number
2
Chromosome location Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
2p23.3
Summary Summary of gene provided in NCBI Entrez Gene.
The protein encoded by this gene acts as a transcriptional coactivator for steroid and nuclear hormone receptors. It is a member of the p160/steroid receptor coactivator (SRC) family and like other family members has histone acetyltransferase activity and
miRNA miRNA information provided by mirtarbase database.
miRTarBase ID miRNA Experiments Reference
MIRT006106 hsa-miR-22-3p Luciferase reporter assay, Western blot 21798241
MIRT006106 hsa-miR-22-3p Luciferase reporter assay, Western blot 21798241
MIRT006106 hsa-miR-22-3p Luciferase reporter assay, Western blot 21798241
MIRT051725 hsa-let-7d-5p CLASH 23622248
MIRT302078 hsa-miR-34a-5p Microarray, qRT-PCR 22815788
Gene ontology (GO) Gene ontology information of associated ontologies with gene provided by GO database.
GO ID Ontology Definition Evidence Reference
GO:0000435 Process Positive regulation of transcription from RNA polymerase II promoter by galactose IDA 10207113
GO:0000785 Component Chromatin IDA 15831516, 17363140
GO:0000785 Component Chromatin ISA
GO:0000977 Function RNA polymerase II transcription regulatory region sequence-specific DNA binding IEA
GO:0002155 Process Regulation of thyroid hormone mediated signaling pathway IEA
Other IDs Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
MIM HGNC e!Ensembl
602691 7668 ENSG00000084676
Protein
UniProt ID Q15788
Protein name Nuclear receptor coactivator 1 (NCoA-1) (EC 2.3.1.48) (Class E basic helix-loop-helix protein 74) (bHLHe74) (Protein Hin-2) (RIP160) (Renal carcinoma antigen NY-REN-52) (Steroid receptor coactivator 1) (SRC-1)
Protein function Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Involved in the coactivation of different nuclear receptors, such as for steroids (PGR, GR and ER),
PDB 1FM6 , 1FM9 , 1K4W , 1K74 , 1K7L , 1KV6 , 1N4H , 1NQ7 , 1NRL , 1P8D , 1PZL , 1RDT , 1TFC , 1U3R , 1U3S , 1X76 , 1X78 , 1X7B , 1X7J , 1XIU , 1XV9 , 1XVP , 1YY4 , 1YYE , 1ZAF , 2A3I , 2C52 , 2FVJ , 2GTK , 2HBH , 2HC4 , 2HCD , 2HFP , 2NPA , 2NV7 , 2P54 , 2PRG , 3BEJ , 3BQD , 3CTB , 3CWD , 3DCT , 3DCU , 3DR1 , 3ET1 , 3ET3 , 3FEI , 3FEJ , 3FUR , 3FXV , 3G8I
Family and domains

Pfam

Accession ID Position in sequence Description Type
PF00010 HLH 26 81 Helix-loop-helix DNA-binding domain Domain
PF00989 PAS 112 185 PAS fold Domain
PF14598 PAS_11 259 370 Domain
PF16665 NCOA_u2 467 590 Disordered
PF08832 SRC-1 628 708 Steroid receptor coactivator Domain
PF08815 Nuc_rec_co-act 924 971 Nuclear receptor coactivator Domain
PF07469 DUF1518 1149 1205 Domain of unknown function (DUF1518) Domain
PF07469 DUF1518 1212 1268 Domain of unknown function (DUF1518) Domain
Tissue specificity TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15313887, ECO:0000269|PubMed:9427757}.
Sequence
MSGLGDSSSDPANPDSHKRKGSPCDTLASSTEKRRREQENKYLEELAELLSANISDIDSL
SVKPDKCKILKKTVDQIQLMK
RMEQEKSTTDDDVQKSDISSSSQGVIEKESLGPLLLEAL
DGFFFVVNCEGRIVFVSENVTSYLGYNQEELMNTSVYSILHVGDHAEFVKNLLPKSLVNG
VPWPQ
EATRRNSHTFNCRMLIHPPDEPGTENQEACQRYEVMQCFTVSQPKSIQEDGEDFQ
SCLICIARRLPRPPAITGVESFMTKQDTTGKIISIDTSSLRAAGRTGWEDLVRKCIYAFF
QPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTKCKLCYPQSPDMQPFIMG
IHIIDREHSG
LSPQDDTNSGMSIPRVNPSVNPSISPAHGVARSSTLPPSNSNMVSTRINR
QQSSDLHSSSHSNSSNSQGSFGCSPGSQIVANVALNQGQASSQSSNPSLNLNNSPMEGTG
ISLAQFMSPRRQVTSGLATRPRMPNNSFPPNISTLSSPVGMTSSACNNNNRSYSNIPVTS
LQGMNEGPNNSVGFSASSPVLRQMSSQNSPSRLNIQPAKAESKDNKEIAS
ILNEMIQSDN
SSSDGKPLDSGLLHNNDRLSDGDSKYSQTSHKLVQLLTTTAEQQLRHADIDTSCKDVLSC
TGTSNSASANSSGGSCPSSHSSLTERHKILHRLLQEGSPSDITTLSVE
PDKKDSASTSVS
VTGQVQGNSSIKLELDASKKKESKDHQLLRYLLDKDEKDLRSTPNLSLDDVKVKVEKKEQ
MDPCNTNPTPMTKPTPEEIKLEAQSQFTADLDQFDQLLPTLEKAAQLPGLCETDRMDGAV
TSVTIKSEILPASLQSATARPTSRLNRLPELELEAIDNQFGQPGTGDQIPWTNNTVTAIN
QSKSEDQCISSQLDELLCPPTTVEGRNDEKALLEQLVSFLSGKDETELAELDRALGIDKL
VQGGGLDVLSE
RFPPQQATPPLIMEERPNLYSQPYSSPSPTANLPSPFQGMVRQKPSLGT
MPVQVTPPRGAFSPGMGMQPRQTLNRPPAAPNQLRLQLQQRLQGQQQLIHQNRQAILNQF
AATAPVGINMRSGMQQQITPQPPLNAQMLAQRQRELYSQQHRQRQLIQQQRAMLMRQQSF
GNNLPPSSGLPVQMGNPRLPQGAPQQFPYPPNYGTNPGTPPASTSPFSQLAANPEASLAN
RNSMV
SRGMTGNIGGQFGTGINPQMQQNVFQYPGAGMVPQGEANFAPSLSPGSSMVPMPI
PPPQSSLL
QQTPPASGYQSPDMKAWQQGAIGNNNVFSQAVQNQPTPAQPGVYNNMSITVS
MAGGNTNVQNMNPMMAQMQMSSLQMPGMNTVCPEQINDPALRHTGLYCNQLSSTDLLKTE
ADGTQQVQQVQVFADVQCTVNLVGGDPYLNQPGPLGTQKPTSGPQTPQAQQKSLLQQLLT
E
Sequence length 1441
Interactions View interactions
Pathways Pathway information has different metabolic/signaling pathways associated with genes.
  KEGG   Reactome
  Estrogen signaling pathway
Thyroid hormone signaling pathway
Pathways in cancer
Breast cancer
  RORA activates gene expression
Recycling of bile acids and salts
Synthesis of bile acids and bile salts
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
Synthesis of bile acids and bile salts via 27-hydroxycholesterol
PPARA activates gene expression
Endogenous sterols
Transcriptional activation of mitochondrial biogenesis
Activation of gene expression by SREBF (SREBP)
HATs acetylate histones
Transcriptional regulation of white adipocyte differentiation
SUMOylation of transcription cofactors
Regulation of lipid metabolism by PPARalpha
Circadian Clock
Estrogen-dependent gene expression
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
Associated diseases Disease information provided by ClinVar, GenCC, and GWAS databases.
Causal
Disease term Disease name dbSNP ID References
Breast cancer Malignant neoplasm of breast rs587776547, rs1137887, rs137853007, rs587776650, rs80359351, rs80359714, rs121917783, rs104886456, rs121964878, rs80359874, rs80357868, rs80357508, rs387906843, rs80357569, rs80358158
View all (309 more)
20332317
Breast carcinoma Breast Carcinoma rs80359671, rs11540652, rs28934575, rs28897672, rs137886232, rs193922376, rs80357783, rs80359306, rs80359405, rs80359507, rs80359598, rs80358429, rs397507683, rs397515636, rs80359451
View all (71 more)
20332317, 29058716
Marfan syndrome Mammary Carcinoma, Human rs137854456, rs137854457, rs267606796, rs137854458, rs137854459, rs137854460, rs137854470, rs137854471, rs267606797, rs137854461, rs137854462, rs137854463, rs869025419, rs137854464, rs137854465
View all (942 more)
20332317
Prostate cancer Malignant neoplasm of prostate rs121909139, rs121909140, rs121909141, rs121909142, rs121909143, rs606231169, rs606231170, rs137852584, rs137852578, rs137852580, rs137852581, rs137852582 12237244
Unknown
Disease term Disease name Evidence References Source
Endometriosis Endometriosis 22138541 ClinVar
Breast Cancer Breast Cancer Importantly, breast cancer patients bearing PRC2 LOF mutations displayed significantly worse prognosis compared with PRC2 wild-type patients GWAS, CBGDA
Sjogren-Larsson Syndrome Sjogren-Larsson Syndrome GWAS
Lung adenocarcinoma Lung adenocarcinoma Validation that loss of Tgfbr2 results in more aggressive and T cell-excluded KP lung tumors GWAS, CBGDA
Associations from Text Mining
Disease Name Relationship Type References
Bipolar Disorder Associate 27468165
Bone Diseases Associate 22174377
Breast Neoplasms Associate 10688660, 15477868, 19755984, 20003447, 24304549, 24719557, 26621841, 27107013, 28973975
Breast Neoplasms Inhibit 24705462
Carcinoma Associate 34067464
Carcinoma Hepatocellular Associate 28060733
Colorectal Neoplasms Associate 32764874
Coronary Aneurysm Associate 24652666
Diabetes Mellitus Type 1 Associate 33083497
Diabetic Nephropathies Associate 32922187